Evidence map›Paper›PMID 37531430›Full record

ArticleScience advances2023

SUMO-activated target traps (SATTs) enable the identification of a comprehensive E3-specific SUMO proteome.

Daniel Salas-Lloret, Nicolette S Jansen, Easa Nagamalleswari, Coen van der Meulen, Ekaterina Gracheva, Arnoud H de Ru, H Anne Marie Otte, Peter A van Veelen, Andrea Pichler, Joachim Goedhart and 2 more

Abstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The SUMO Pathway.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. SUMO and the DNA damage response.Biochemical Society transactions · 2024
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daniel Salas-LloretCell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0001-7336-2887
Nicolette S JansenCell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.
Easa NagamalleswariMax Plank Institute for Immunobiology and Epigenetics, Freiburg, Germany.
Coen van der MeulenCell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-6624-3246
Ekaterina GrachevaCell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.
Arnoud H de RuCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
H Anne Marie OtteCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.
Peter A van VeelenCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-7898-9408
Andrea PichlerMax Plank Institute for Immunobiology and Epigenetics, Freiburg, Germany.ORCID 0000-0003-0728-7334
Joachim GoedhartUniversity of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0002-0630-3825
Alfred C O VertegaalCell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-7989-0493
Román González-PrietoCell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0001-8997-2321

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ubiquitin and ubiquitin-like conjugation cascades consist of dedicated E1, E2, and E3 enzymes with E3s providing substrate specificity. Mass spectrometry-based approaches have enabled the identification of more than 6500 SUMO2/3 target proteins. The limited number of SUMO E3s provides the unique opportunity to systematically study E3 substrate wiring. We developed SUMO-activated target traps (SATTs) and systematically identified substrates for eight different SUMO E3s, PIAS1, PIAS2, PIAS3, PIAS4, NSMCE2, ZNF451, LAZSUL (ZNF451-3), and ZMIZ2. SATTs enabled us to identify 427 SUMO1 and 961 SUMO2/3 targets in an E3-specific manner. We found pronounced E3 substrate preference. Quantitative proteomics enabled us to measure substrate specificity of E3s, quantified using the SATT index. Furthermore, we developed the Polar SATTs web-based tool to browse the dataset in an interactive manner. Overall, we uncover E3-to-target wiring of 1388 SUMO substrates, highlighting unique and overlapping sets of substrates for eight different SUMO E3 ligases.

Indexed as

ProteomeUbiquitin-Protein LigasesUbiquitinProteomeUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID37531430
PMCPMC10396300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.